Smoldering Multiple MyelomaSymptoms, Doctors, Treatments, Advances & More
Learn About Smoldering Multiple Myeloma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Office
Robert Orlowski is an Oncologist practicing medicine in Houston, Texas. Dr. Orlowski is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Plasmacytoma, Smoldering Multiple Myeloma, Endometrial Cancer, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center
Paul Richardson is a Hematologist Oncology specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Richardson is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Hepatic Venoocclusive Disease with Immunodeficiency, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Graft. Dr. Richardson is board certified in Medical Oncology. Dr. Richardson is currently accepting new patients.
Dana-Farber Cancer Institute, Lipper Multiple Myeloma Center
Jacob Laubach is an Oncologist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Laubach is rated as an Elite provider by MediFind in the treatment of Smoldering Multiple Myeloma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Laubach is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Laubach is currently accepting new patients.
Summary: This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma. Drugs used in chemotherapy, such as lenalidomide and dexamethasone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with...
Summary: This study is researching an experimental drug called linvoseltamab (also called study drug) compared to another drug called daratumumab, in participants with Smoldering Multiple Myeloma (SMM), who are at a High Risk (HR) of developing active multiple myeloma. The aim of this study is to find out whether linvoseltamab is better than daratumumab in delaying the development of MM. The study is looki...